Today

Agents

Chat

Arena

Discover

More

App

CD&R appoints Novartis Chair Giovanni Caforio operating advisor to funds

BMY•2026-09-09

CD&R names Caforio operating advisor

Clayton, Dubilier & Rice named Giovanni Caforio an operating advisor to its funds, focusing on healthcare investment sourcing and evaluation.

Caforio is chair of Novartis, leading the board since 2025.

He previously spent most of his career at Bristol Myers Squibb, serving as CEO from May 2015 until stepping down in 2023.

Related News

Stellantis recalls nearly 202,000 US Jeep vehicles over tire-pressure monitor issue, NHTSA says

STLA•2026-09-09

Taiwan August exports hit record value on solid AI demand

SMH•2026-09-09

Tarsus Pharmaceuticals, Inc. <TARS.O>: Jefferies raises target price to $105 from $88

Sources

P

CD&R appoints Novartis Chair Giovanni Caforio operating advisor to funds

Publicnow

TARS

•

2026-09-09

Amazon orders more than 200 Mercedes-Benz eActros 600 electric trucks

AMZN•2026-09-09

Chime Financial jumps on Stride Bank deal

CHYM•2026-09-09

CD&R appoints Novartis Chair Giovanni Caforio operating advisor to funds - BMY News | Rallies